Regarding dissociative brokers (generally ketamine) or a mix of ketamine and an α2 adrenergic receptor agonist, for instance xylazine, there is restricted dialogue of the euthanasia strategy in the current AVMA rules,5 with only one supporting review cited wherein the principal aim was not qualitative evaluation of dissociative agents for https://samuelh934evu0.wikigop.com/user